A major group purchasing organization (GPO) is suing the federal government over a policy that it claims unlawfully restricts how [...] …
Category: Regulatory
Eli Lilly is backing Sanofi’s lawsuit to compel the federal government to release all 340B contract pharmacy agreements, arguing that [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Kalderos, the drug industry vendor behind two 340B claims data submission platforms which support 340B rebates, will file an updated [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Washington state hospital on Tuesday became the fifth provider to sue the federal government for authorizing Johnson & Johnson [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The growth in total 340B purchases last year was largely a result of drugmaker price increases and broader healthcare trends, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug purchases under the 340B program reached $66.3 billion in 2023, marking a 24% increase over the $54 billion in [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical Research and Manufacturers of America (PhRMA) expressed “serious concerns” with the federal government’s opposition to Johnson & Johnson’s (J&J’s) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal regulators’ inaction on the 340B program’s interactions with Medicare drug price negotiations will likely lead drugmakers to pursue “manufacturer-friendly” [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A new federal regulation updating the definition of a covered outpatient drug could change the number of drugs covered under [...] …